Total thyroidectomy with and without selective central compartment dissection: A comparison of complication rates

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 6, 2010, Pages 584-587

  Shindo, Maisie ^a   Stern, Anna ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHYLE; CONTROLLED STUDY; FEMALE; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NODULAR GOITER; ONCOCYTOMA; PARESIS; POSTOPERATIVE COMPLICATION; SEROMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY; VOCAL CORD PARALYSIS;

CHYLE; FEMALE; HEMATOMA; HUMANS; HYPOCALCEMIA; LYMPH NODE EXCISION; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEROMA; THYROIDECTOMY; VOCAL CORD PARALYSIS;

EID: 77953880450     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.79     Document Type: Article

References (22)

1. Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg. 2004;130(10):1214-1216. (Pubitemid 39371970)
2. Uruno T, Miyauchi A, Shimizu K, et al. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today. 2004;34(11):891-895. (Pubitemid 40326464)
3. Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery. 2004;136(6):1183-1191.
4. Frederick LG, David LP, Irvin DF, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag NY Inc; 2002:77-87.
5. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg. 1998;383(2):167-169. (Pubitemid 28442533)
6. Cheah WK, Arici C, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Complications of neck dissection for thyroid cancer. World J Surg. 2002;26(8):1013-1016. (Pubitemid 36920301)
7. Shindo M, Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2006;132(6):650-654. (Pubitemid 43927043)
8. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.
9. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg. 2007;245(4):604-610.
10. Cavicchi O, Piccin O, Caliceti U, De Cataldis A, Pasquali R, Ceroni AR. Transient hypoparathyroidism following thyroidectomy: a prospective study and multivariate analysis of 604 consecutive patients. Otolaryngol Head Neck Surg. 2007;137(4):654-658. (Pubitemid 47445879)
11. Lee YS, Kim SW, Kim SW, et al. Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg. 2007;31(10):1954-1959. (Pubitemid 47415715)
12. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery. 2006;140(6):1000-1007. (Pubitemid 44937385)
13. Shah MD, Hall FT, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope. 2003;113(12):2102-2107. (Pubitemid 38063829)
14. Steinmüller T, Klupp J, Rayes N, et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg. 2000;166(1):29-33. (Pubitemid 30062584)
15. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 2004;114(3):393-402. (Pubitemid 38391898)
16. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106(3):524-531. (Pubitemid 43157614)
17. Tisell LE, Nilsson B, Molne J, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20(7):854-859. (Pubitemid 26281914)
18. Simon D, Goretzki PE, Witte J, Röher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg. 1996;20(7):860-866. (Pubitemid 26281915)
19. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18(4):559-568. (Pubitemid 24273857)
20. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31(5):895-904. (Pubitemid 46716783)
21. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30(1):91-99. (Pubitemid 43081619)
22. Salter KD, Andersen PE, Cohen JI. Central nodal metastases in papillary thyroid carcinoma based on tumor histology and focality. Arch Otolaryngol Head Neck Surg. In press.